Last updated on August 2018

A clinical trial sponsored by Hoffmann-La Roche for a research study of Lampalizumab

Brief description of study

This multicenter open-label extension study is designed to evaluate the safety and tolerability of lampalizumab intravitreal injections in participants with GA secondary to age-related macular degeneration (AMD) who completed 96 weeks of treatment in Studies GX29176 (NCT02247479) or GX29185 (NCT02247531). The extension will enroll participants from the parent studies who received investigational lampalizumab, as well as lampalizumab-naive participants exposed to sham comparator. All participants will receive open-label lampalizumab in the present study.

Clinical Study Identifier: NCT02745119

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: GX30191 ...

Southern CA Desert Retina Cons
Palm Desert, CA United States

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.